Enstilar and Abdominal pain upper - a phase IV clinical study of FDA data

Summary:

Abdominal pain upper is reported as a side effect among people who take Enstilar (betamethasone dipropionate; calcipotriene), especially for people who are male, 60+ old, also take Cosentyx, and have Psoriasis.

The phase IV clinical study analyzes which people have Abdominal pain upper when taking Enstilar. It is created by eHealthMe based on reports of 1,668 people who have side effects when taking Enstilar from the FDA, and is updated regularly.

What is Enstilar?

Enstilar has active ingredients of betamethasone dipropionate; calcipotriene. eHealthMe is studying from 1,673 Enstilar users. Check the latest studies of Enstilar.

What is Abdominal pain upper?

Abdominal pain upper is found to be associated with 3,069 drugs and 4,280 conditions by eHealthMe. Check the latest studies of Abdominal pain upper.

On Jan, 06, 2026

1,668 people reported to have side effects when taking Enstilar.
Among them, 34 people (2.04%) have Abdominal pain upper.

Could Enstilar cause Abdominal pain upper?

Among these 34 people:

What is the gender of people who have Abdominal pain upper when taking Enstilar? *

female: 38.24 %
male: 61.76 %

What is the age of people who have Abdominal pain upper when taking Enstilar? *

What are other drugs people take besides Enstilar? *

What are other side effects people have besides Abdominal pain upper? *

Diarrhea: 14 people, 41.18%
Pain: 12 people, 35.29%
Psoriasis (immune-mediated disease that affects the skin): 11 people, 32.35%
Abdominal Discomfort: 9 people, 26.47%
Nausea (feeling of having an urge to vomit): 9 people, 26.47%
Weakness: 9 people, 26.47%
Rashes (redness): 9 people, 26.47%
Abdominal Pain: 8 people, 23.53%
Weight Decreased: 7 people, 20.59%
Urticaria (rash of round, red welts on the skin that itch intensely): 7 people, 20.59%

What are the existing conditions these people have? *

Psoriasis (immune-mediated disease that affects the skin): 21 people, 61.76%
Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 16 people, 47.06%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 5 people, 14.71%
Neuroendocrine Tumor: 4 people, 11.76%
Insomnia (sleeplessness): 4 people, 11.76%
Heart Disease: 4 people, 11.76%
Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 2 people, 5.88%
Drowsiness: 2 people, 5.88%
Cataplexy (loss of muscle tone accompanied by full conscious awareness): 2 people, 5.88%
Neurodermatitis (a skin disorder characterized by long lasting itching and scratching): 1 person, 2.94%

* Approximation only. Some reports may have incomplete information.

Do you take Enstilar and have Abdominal pain upper?

- Check whether Abdominal pain upper is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Enstilar:

Enstilar (1,673 reports)

Abdominal pain upper treatments and more:

Abdominal pain upper (243,364 reports)

How severe was Abdominal pain upper and when was it recovered:

Abdominal pain upper in Enstilar

Expand to all the drugs that have ingredients of betamethasone dipropionate; calcipotriene:

Abdominal pain upper and drugs with ingredients of betamethasone dipropionate; calcipotriene

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Enstilar:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Abdominal pain upper:

Abdominal pain upper (3,069 drugs)

Browse all the conditions that are associated with Abdominal pain upper:

Abdominal pain upper (4,280 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on betamethasone dipropionate; calcipotriene (the active ingredients of Enstilar) and Enstilar (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.